Insulin resistance and impaired insulin secretion due to phosphofructo-1-kinase-deficiency in humans

[1]  J. Malin,et al.  Muscle phosphofructokinase deficiency in two generations , 1996, Journal of Neurological Sciences.

[2]  K. Feldmann,et al.  New isoniazid/ethionamide resistance gene mutation and screening for multidrug- resistant Mycobacterium tuberculosis strains , 1995, The Lancet.

[3]  D. Bartlett,et al.  Reversal of tumor-associated hyperglucagonemia as treatment for cancer cachexia. , 1995, Surgery.

[4]  G. Velho,et al.  A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus , 1995, Nature Genetics.

[5]  Y. Yazaki,et al.  A subtype of diabetes mellitus associated with a mutation in the mitochondrial gene , 1995, Muscle & nerve. Supplement.

[6]  B. Corkey,et al.  Phosphofructokinase isozymes in pancreatic islets and clonal beta-cells (INS-1). , 1995, Diabetes.

[7]  C. Eng,et al.  Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency. , 1994, American journal of human genetics.

[8]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[9]  D. Accili,et al.  Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM? , 1994, Diabetes.

[10]  S. Kageyama,et al.  Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin). , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  S. Nagataki,et al.  Cloning of a complete protein-coding sequence of human platelet-type phosphofructokinase isozyme from pancreatic islet. , 1994, Biochemical and biophysical research communications.

[12]  M. Permutt,et al.  Polymorphic Microsatellite Repeat Markers at the Glucokinase Gene Locus Are Positively Associated With NIDDM in Japanese , 1993, Diabetes.

[13]  Y. Yazaki,et al.  Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[14]  P. Froguel,et al.  Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[15]  L. Groop,et al.  Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[16]  M. Permutt,et al.  Glucokinase and NIDDM: A Candidate Gene That Paid Off , 1992, Diabetes.

[17]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[18]  M. Permutt,et al.  Glucokinase Gene is Genetic Marker for NIDDM in American Blacks , 1992, Diabetes.

[19]  R. O’Brien,et al.  Molecular Physiology and Genetics of NIDDM: Importance of Metabolic Staging , 1992, Diabetes Care.

[20]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[21]  H. Yki-Järvinen Glucose toxicity. , 1992, Endocrine reviews.

[22]  S. Lillioja,et al.  Basal and insulin-mediated carbohydrate metabolism in human muscle deficient in phosphofructokinase 1. , 1991, The American journal of physiology.

[23]  R. Haller,et al.  Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. , 1991, The New England journal of medicine.

[24]  S. Massry,et al.  Inhibition of phosphofructokinase activity in pancreatic islets in phosphate depletion. , 1991, Mineral and electrolyte metabolism.

[25]  S. Massry,et al.  Phosphate depletion impairs insulin secretion by pancreatic islets. , 1991, Kidney international.

[26]  D. Owens,et al.  INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[27]  R. DeFronzo The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[28]  R. DeFronzo Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[29]  T. Kasten,et al.  Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. , 1988, The Biochemical journal.

[30]  Marinos C. Dalakas,et al.  Muscle biopsy — a practical approach , 1986, The Ulster Medical Journal.

[31]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[32]  S. Dimauro,et al.  Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency. , 1983, The Journal of clinical investigation.

[33]  G. Baule,et al.  Hemoglobin A1 in subjects with G-6-PD deficiency during and after hemolytic crises due to favism. , 1983, Acta haematologica.

[34]  P. Marbach,et al.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.

[35]  G. Reaven,et al.  Assessment of Insulin Resistance with the Insulin Suppression Test and the Euglycemic Clamp , 1981, Diabetes.

[36]  E. Van Schaftingen,et al.  Is the glucose‐induced stimulation of glycolysis in pancreatic islets attributable to activation of phosphofructokinase by fructose 2,6‐bisphosphate? , 1981, FEBS letters.

[37]  A. Goldhammer,et al.  Phosphofructokinase: structure and function. , 1979, Current topics in cellular regulation.

[38]  J. Kaplan,et al.  International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis * , 1977, British journal of haematology.

[39]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[40]  E. Bonilla,et al.  Histochemical diagnosis of muscle phosphofructokinase deficiency. , 1970, Archives of neurology.

[41]  R. Layzer,et al.  Muscle phosphofructokinase deficiency. , 1967, Archives of neurology.

[42]  C. Angelini,et al.  Enzymes of the glycogen cycle and glycolysis in various human neuromuscular disorders. , 1967, Journal of neurology, neurosurgery, and psychiatry.

[43]  R. Harbeck,et al.  Influence of age on intravenous glucose tolerance and serum immunoreactive insulin. , 1966, Lancet.

[44]  T. Tanaka,et al.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS. , 1965, Biochemical and biophysical research communications.